FR2576787B1 - Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle - Google Patents

Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle

Info

Publication number
FR2576787B1
FR2576787B1 FR868601477A FR8601477A FR2576787B1 FR 2576787 B1 FR2576787 B1 FR 2576787B1 FR 868601477 A FR868601477 A FR 868601477A FR 8601477 A FR8601477 A FR 8601477A FR 2576787 B1 FR2576787 B1 FR 2576787B1
Authority
FR
France
Prior art keywords
sustained release
release formulation
formulation containing
ergot alkaloids
containing rye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR868601477A
Other languages
English (en)
Other versions
FR2576787A1 (fr
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2576787A1 publication Critical patent/FR2576787A1/fr
Application granted granted Critical
Publication of FR2576787B1 publication Critical patent/FR2576787B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR868601477A 1985-02-05 1986-01-31 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle Expired - Lifetime FR2576787B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (2)

Publication Number Publication Date
FR2576787A1 FR2576787A1 (fr) 1986-08-08
FR2576787B1 true FR2576787B1 (fr) 1990-01-12

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868601477A Expired - Lifetime FR2576787B1 (fr) 1985-02-05 1986-01-31 Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle

Country Status (24)

Country Link
JP (1) JPS61183225A (fr)
KR (1) KR920010388B1 (fr)
AU (1) AU597570B2 (fr)
BE (1) BE904152A (fr)
CA (1) CA1263087A (fr)
CH (1) CH667592A5 (fr)
CY (1) CY1604A (fr)
DE (1) DE3602577A1 (fr)
DK (1) DK167138B1 (fr)
ES (1) ES8800040A1 (fr)
FR (1) FR2576787B1 (fr)
GB (1) GB2170407B (fr)
GR (1) GR860310B (fr)
HK (1) HK57191A (fr)
HU (1) HU195729B (fr)
IE (1) IE59293B1 (fr)
IT (1) IT1191255B (fr)
LU (1) LU86289A1 (fr)
NL (1) NL8600161A (fr)
NZ (1) NZ215020A (fr)
PH (1) PH23384A (fr)
PT (1) PT81954B (fr)
SE (1) SE8600496L (fr)
SG (1) SG56191G (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
CA2393344C (fr) * 1999-12-03 2009-09-01 Polichem S.A. Procedes permettant la preparation de compositions pharmaceutiques a liberation prolongee d'alcaloides d'ergot presentant une biodisponibilite amelioree et compositions ainsi obtenues
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
DE60132444T2 (de) 2000-05-12 2009-01-22 Meracol Corp. Ltd., Takapuna Behandlung von reizkolon-syndrom oder -krankheit
ES2298237T3 (es) * 2000-05-12 2008-05-16 Meracol Corporation Limited Cetil miristato y cetil palmitato para el tratamiento del eczema y/o de la soriasis.
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2003026640A1 (fr) * 2001-09-28 2003-04-03 Meracol Corporation Limited Traitement d'allergies alimentaires et/ou d'intolerances alimentaires
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
DK167138B1 (da) 1993-09-06
HUT41984A (en) 1987-06-29
LU86289A1 (fr) 1986-09-02
IE59293B1 (en) 1994-02-09
CH667592A5 (de) 1988-10-31
IT1191255B (it) 1988-02-24
PT81954B (pt) 1988-07-01
BE904152A (fr) 1986-08-04
SG56191G (en) 1991-08-23
GR860310B (en) 1986-05-27
HK57191A (en) 1991-08-02
GB2170407A (en) 1986-08-06
CY1604A (en) 1992-04-03
GB2170407B (en) 1988-10-26
KR860006265A (ko) 1986-09-09
NZ215020A (en) 1989-07-27
JPS61183225A (ja) 1986-08-15
IT8647620A0 (it) 1986-02-05
IE860291L (en) 1986-08-05
KR920010388B1 (ko) 1992-11-27
DE3602577A1 (de) 1986-08-28
AU5294286A (en) 1986-08-14
CA1263087A (fr) 1989-11-21
HU195729B (en) 1988-07-28
SE8600496L (sv) 1986-08-06
DK52086A (da) 1986-08-06
DK52086D0 (da) 1986-02-03
NL8600161A (nl) 1986-09-01
PT81954A (en) 1986-03-01
ES8800040A1 (es) 1987-10-16
ES551635A0 (es) 1987-10-16
AU597570B2 (en) 1990-06-07
GB8602602D0 (en) 1986-03-12
FR2576787A1 (fr) 1986-08-08
PH23384A (en) 1989-07-26
SE8600496D0 (sv) 1986-02-04

Similar Documents

Publication Publication Date Title
GB2193632B (en) Oral sustained release forms of carbamazepine
GB2153675B (en) Device for sustained release of active substance
GB2182343B (en) Toilet soap composition
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
AU6618186A (en) Resinate sustained release dextromethorphan composition
IT8620766A1 (it) Mescole-madri per l'opacizzazione di poliammidi
NO176805C (no) Slippmiddelblanding
NZ214534A (en) Sustained release formulation containing theophylline
FR2576787B1 (fr) Formulation a liberation prolongee contenant des alcaloides de l'ergot de seigle
BE892884A (fr) Composition analgesique a base de butorphanol et de zomepirac
GB2155335B (en) Device for sustained release of medicinal substances
FR2508313B1 (fr) Nouvelles formulations pharmaceutiques a base d'alcaloides de l'ergot de seigle et leur preparation
FR2583995B1 (fr) Generateur d'aerosol
IT1188327B (it) Dispositivo per misurare l'accelerazione di parti di veicoli
GB2173101B (en) Dopaminergic compositions containing dihydroergocryptine
GB8628827D0 (en) Application of wax
GB2178748B (en) Novel flameproofing agents
FR2595049B1 (fr) Structure de prises amovibles pour mur d'escalade
DE3664784D1 (en) Use of a spirolactone as a perfuming agent
GB2189391B (en) Use of chemical compounds
KR860011352U (ko) 배낭의 보조가방 연결구
IL74970A0 (en) Sustained release tablets of theophylline
ZA889365B (en) Hydrates of andinotropic agent
GB8713080D0 (en) Recordal of events
ZA86848B (en) Pharmaceutical 9,-10-dihydrogenated ergot alkaloid containing compositions

Legal Events

Date Code Title Description
ST Notification of lapse